Inventor
MASON JONATHAN STEPHEN
GB17 patents
⚠️ This page may combine multiple inventors who share the name “MASON JONATHAN STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HEPTARES THERAPEUTICS LTD
11 patentsUS10112923B2Oct 30, 2018
1,2,4-triazine-4-amine derivatives
HEPTARES THERAPEUTICS LTD20 citations93
US9925178B2Mar 27, 2018
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD4 citations83
US9808457B2Nov 7, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD6 citations83
US9688660B2Jun 27, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD5 citations83
US10988455B2Apr 27, 2021
1,2,4-triazine-4-amine derivatives
HEPTARES THERAPEUTICS LTD1 citations72
US10888561B2Jan 12, 2021
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10300056B2May 28, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10259812B2Apr 16, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD2 citations72
US10166226B2Jan 1, 2019
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD3 citations72
US9802935B2Oct 31, 2017
CGRP receptor antagonists
HEPTARES THERAPEUTICS LTD4 citations72
US9249130B2Feb 2, 2016
1,2,4-triazine-4-amine derivatives
HEPTARES THERAPEUTICS LTD3 citations72
NXERA PHARMA UK LTD
4 patentsUS12178813B2Dec 31, 2024
CGRP receptor antagonists
NXERA PHARMA UK LTD0 citations61
US12054472B2Aug 6, 2024
1,2,4-triazine-4-amine derivatives
NXERA PHARMA UK LTD0 citations61
US12552799B2Feb 17, 2026
Triazolone compounds
NXERA PHARMA UK LTD0 citations50
US12528815B2Jan 20, 2026
5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer
NXERA PHARMA UK LTD0 citations48